Virtu Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Virtu Financial’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,422	Closed	-$382K	–	2246
2017 Q4	$382K	Sell	7,422 -5,187	-41%	-$267K	0.02%	1060
2017 Q3	$657K	Buy	+12,609	New	+$647K	0.03%	702
2016 Q3	–	Sell	-57,960	Closed	-$2.79M	–	427
2016 Q2	$2.79M	Buy	+57,960	New	+$2.76M	0.37%	51

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Virtu Financial's IHE Position: Q1 2018 in Review

Virtu Financial sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 7,422 shares — an estimated $382K sold.

Virtu Financial first reported a position in IHE in Q2 2016 and held it in 3 quarters. The position peaked at $2.79M in Q2 2016. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.

Virtu Financial reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Virtu Financial sold 7,422 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $382K.
Virtu Financial first reported a position in iShares US Pharmaceuticals ETF in Q2 2016 and held it in 3 quarters.
Virtu Financial's iShares US Pharmaceuticals ETF position peaked at $2.79M in Q2 2016.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.